ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,626Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 783

$1.32M Total Retail Price of All Prescriptions

Rank: 18 out of 783

830 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 830 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 830 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 16,671 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
AMLODIPINE BESYLATE 983 882 1 5
LISINOPRIL 961 802 2 4
LEVOTHYROXINE SODIUM 853 735 3 1
SIMVASTATIN 705 591 4 3
HYDROCODONE-ACETAMINOPHEN 625 420 S3 5 2
OMEPRAZOLE 599 456 6 6
PRAVASTATIN SODIUM 510 432 7 14
FUROSEMIDE 487 422 8 7
ATORVASTATIN CALCIUM 479 392 9 11
METFORMIN HCL 417 307 10 8
ATENOLOL 355 317 11 17
HYDROCHLOROTHIAZIDE 348 324 12 12
LOSARTAN POTASSIUM 342 297 13 18
METOPROLOL TARTRATE 327 255 14 9
ZOLPIDEM TARTRATE 296 203 15 23
GLIMEPIRIDE 287 250 16 34
METOPROLOL SUCCINATE 282 252 17 13
PAROXETINE HCL 259 208 18 69
TRIAMTERENE-HCTZ 235 187 19 42
POTASSIUM CHLORIDE 233 199 20 16
GABAPENTIN 229 163 21 15
TAMSULOSIN HCL 208 187 22 26
WARFARIN SODIUM 194 168 23 10
DOXAZOSIN MESYLATE 185 185 24 87
NEXIUM 184 139 25 28
LOVASTATIN 183 164 26 58
FLUOXETINE HCL 180 144 27 45
TRAMADOL HCL 180 143 27 20
KLOR-CON M20 176 148 29 48
CARVEDILOL 175 155 30 21
ALENDRONATE SODIUM 175 162 30 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 163 153 32 33
ALLOPURINOL 161 130 33 31
FENOFIBRATE 152 135 34 66
CRESTOR 151 109 35 27
CITALOPRAM HBR 135 95 36 19
PANTOPRAZOLE SODIUM 133 107 37 30
SERTRALINE HCL 133 99 37 22
AMITRIPTYLINE HCL 126 104 R 39 77
DONEPEZIL HCL 121 121 40 24
OXYCODONE HCL-ACETAMINOPHEN 112 55 S2 41 86
TRAZODONE HCL 111 78 42 39
CLOPIDOGREL 111 89 42 29
ADVAIR DISKUS 107 90 44 50
LOSARTAN-HYDROCHLOROTHIAZIDE 105 99 45 53
PREDNISONE 104 72 46 36
EVISTA 100 97 47 92
DIOVAN 98 98 48 49
SPIRIVA 95 81 49 59
PLAVIX 94 77 50 51
NAPROXEN 93 88 51 104
TRICOR 88 80 52 134
LANTUS 88 64 52 38
CYCLOBENZAPRINE HCL 87 24 R 54 63
FLUTICASONE PROPIONATE 82 62 55 46
INSULIN SYRINGE 80 56 56 82
CLONIDINE HCL 79 47 57 60
ISOSORBIDE MONONITRATE ER 78 69 58 40
FENTANYL 78 57 S2 58 65
CELEBREX 77 64 60 93
PROAIR HFA 76 39 61 56
RANITIDINE HCL 76 54 61 44
MELOXICAM 76 49 61 37
VERAPAMIL ER 74 67 64 119
NITROSTAT 74 35 64 191
DIOVAN HCT 73 66 66 94
DOXYCYCLINE HYCLATE 71 57 67 112
FINASTERIDE 71 58 67 127
SYNTHROID 69 63 69 47
JANUVIA 68 64 70 73
COMBIVENT 68 58 70 120
DIGOXIN 67 67 72 61
GLIPIZIDE 67 64 72 71
ROPINIROLE HCL 64 45 74 74
ZETIA 64 57 74 80
OXYBUTYNIN CHLORIDE 63 55 76 96
DICLOFENAC SODIUM 63 46 76 139
PROMETHAZINE HCL 62 19 R 78 97
DILTIAZEM 24HR CD 59 59 79 118
METFORMIN HCL ER 59 50 79 64
PEN NEEDLE 58 43 81 103
NAMENDA 57 45 82 32
ESCITALOPRAM OXALATE 56 33 83 54
TERAZOSIN HCL 55 55 84 130
DILTIAZEM ER 55 45 84 153
LIPITOR 55 40 84 114
OXYCODONE-ACETAMINOPHEN 54 31 S2 87 76
OXYBUTYNIN CHLORIDE ER 51 34 88 117
ACTOS 51 43 88 149
CYMBALTA 51 30 88 35
HUMALOG 50 35 91 101
RAMIPRIL 50 46 91 113
GLIPIZIDE ER 50 47 91 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.